65757-401
Generic: aripiprazole lauroxil
Labeler: alkermes, inc.Drug Facts
Product Profile
Brand Name
Generic Name
aripiprazole lauroxil
Labeler
alkermes, inc.
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Active Ingredients
aripiprazole lauroxil 441 mg/1.6mL
Identifiers & Regulatory
Product NDC
65757-401
Product ID
65757-401_ba3f1fc1-2263-4c0a-81d1-2f068edbca72
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2015-10-05
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65757401
Hyphenated Format
65757-401
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
aristada (source: label)
Generic Name
aripiprazole lauroxil (source: ndc)
Application Number
NDA207533 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 441 mg/1.6mL
Packaging
- 20 TRAY in 1 CARTON (65757-401-00) / 15 SYRINGE in 1 TRAY / 1.6 mL in 1 SYRINGE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "ba3f1fc1-2263-4c0a-81d1-2f068edbca72", "openfda": {}, "finished": false, "packaging": [{"description": "20 TRAY in 1 CARTON (65757-401-00) / 15 SYRINGE in 1 TRAY / 1.6 mL in 1 SYRINGE", "package_ndc": "65757-401-00", "marketing_start_date": "05-OCT-15"}], "product_id": "65757-401_ba3f1fc1-2263-4c0a-81d1-2f068edbca72", "dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE", "product_ndc": "65757-401", "generic_name": "aripiprazole lauroxil", "labeler_name": "Alkermes, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "ARIPIPRAZOLE LAUROXIL", "strength": "441 mg/1.6mL"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20151005", "listing_expiration_date": "20261231"}